Vir Biotechnology Inc (VIR) — Free Cash Flow Generation Index

Latest as of December 2022: 0.64x

Vir Biotechnology Inc (VIR) has a Free Cash Flow Generation Index of 0.64x as of December 2022. Free cash flow of $22.53 Million represents 1% of operating cash flow ($35.13 Million). Read VIR liabilities breakdown for a breakdown of total debt and financial obligations.

FCF Generation Index

0.64x
Free Cash Flow / Operating CF

Free Cash Flow

$22.53 Million
USD

Operating Cash Flow

$35.13 Million
USD

Capital Expenditures

$12.60 Million
USD

Vir Biotechnology Inc Free Cash Flow Generation Index (2022–2022)

Historical FCF Generation Index trend for Vir Biotechnology Inc across 1 annual periods. Explore Vir Biotechnology Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Vir Biotechnology Inc (2022–2022)

Year-by-year Free Cash Flow Generation Index for Vir Biotechnology Inc. For the full company profile including market capitalisation, see Vir Biotechnology Inc (VIR) total market value.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2022 0.96x $1.60 Billion $1.66 Billion $68.01 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).